{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:51:19Z","timestamp":1781682679498,"version":"3.54.5"},"reference-count":7,"publisher":"Norwegian Medical Association","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.18.0253","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T08:15:47Z","timestamp":1523952947000},"source":"Crossref","is-referenced-by-count":0,"title":["Kan man patentere solen?"],"prefix":"10.4045","volume":"138","author":[{"given":"Lars","family":"Sl\u00f8rdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"key":"ref=1","unstructured":"Could you patent the sun? https:\/\/www.youtube.com\/watch?v=erHXKP386Nk\u00a0(28.2.2018)."},{"key":"ref=2","unstructured":"Center for Drug Evaluation and Research. Application number: 209531Orig1s000: Office Director Memo. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2016\/209531Orig1s000ODMemo.pdf (28.2.2018)."},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Wikipedia. Nusinersen. https:\/\/en.wikipedia.org\/wiki\/Nusinersen (28.2.2018).","DOI":"10.4324\/9781315679099-3"},{"key":"ref=4","unstructured":"Statens legemiddelverk. Hurtig metodevurdering av Spinraza (nusinersen). https:\/\/legemiddelverket.no\/nyheter\/hurtig-metodevurdering-av-spinraza-nusinersen (28.2.2018)"},{"key":"ref=5","unstructured":"Beslutningsforum for nye metoder. Forel\u00f8pig protokoll for m\u00f8te 12.2.2018. https:\/\/nyemetoder.no\/Documents\/Beslutninger\/Beslutningsforum%2020180212%20-%20protokoll%20forel%c3%b8pig.pdf (28.2.2018)."},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Finkel\u00a0RS, Mercuri\u00a0E, Darras\u00a0BT et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 2017; 377: 1723\u201332. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29091570&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJMoa1702752","DOI":"10.1056\/NEJMoa1702752"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Mercuri\u00a0E, Darras\u00a0BT, Chiriboga\u00a0CA et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med 2018; 378: 625\u201335. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29443664&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056%2FNEJMoa1710504","DOI":"10.1056\/NEJMoa1710504"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:51:19Z","timestamp":1781679079000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2018\/04\/leder\/kan-man-patentere-solen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,16]]},"references-count":7,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,4,17]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.18.0253","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,16]]}}}